We are looking for team members at all levels. If you are interested in joining our team, please look for more information here. We are looking forward to hearing from you!

Gabrijela_Dumbovic copy_edited.jpg

Dr. sc. Gabrijela Dumbović, Group leader

Gabrijela Dumbovic is a Group Leader at the Institute for Cardiovascular Regeneration at the Goethe University Frankfurt. She received her Ph.D. in 2017 working on long non-coding RNAs from macrosatellite repeats in colon cancer in the laboratory of Dr. Perucho & Dr. Forcales at the Institute for Predictive and Personalized Medicine of Cancer in Barcelona, Spain. She carried out her postdoctoral work in the laboratory of Dr. Rinn at BioFrontiers in the U.S. where she worked on long non-coding RNA biology and novel aspects of subcellular RNA localization regulation. She joined the Max Planck Institute for Immunobiology and Epigenetics in the lab of Dr. Grün for a brief period before starting her lab to specialize in high throughput single-molecule RNA imaging and quantitative single cell biology. Her lab studies long non-coding RNAs and subcellular RNA localization regulation in relevant disease models.

Colin Bodemer, Ph.D. student


Rebeca obtained her Bachelor in Biotechnology and later received her Masters in Biotechnology from the University of São Paulo (USP), Brazil, in 2020. She developed her Masters' project in the group of Dr. Barazzone at Instituto Butantan focusing on the development of new vaccine candidates against a neglected tropical disease, where she gained experience in molecular biology and protein biochemistry. Before joining Dr. Dumbović's lab for her PhD, she worked as MTA in the Cardiovascular Phisiology group leaded by Prof. Heineke at the Universitätsmedizin Mannheim, where she had her first contact and got interested in the study of long non-coding RNAs and their effects in health and disease.

Berkay Erdem, Technical assistant

Lichtbild Colin Bodemer[100] copy 2.jpg

Colin received his M.S. degree in 2021 at the Hannover Medical School. During his Masters training, Colin worked with non-coding RNAs in the cardiovascular system in the group of Dr. Bär at the Institute of Molecular and Translational Therapeutic Strategies in Hannover. Furthermore, he gained experience in small non-coding RNAs at the Department of Epigenomics of the Institute of Human Genetics, where he worked on miRNA-449 and its role in liver cancer. His Master’s project was dedicated towards developing therapeutic strategies for amyotrophic lateral sclerosis using ALS mouse models in the group of Prof. Dr. Petri at Hannover Medical School.

Berkay received his M.Sc. degree in 2021 from Friedrich Schiller University Jena. He completed his Master’s project in The Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) in the group of Prof. Englert where he obtained experience in animal experiments and molecular biology. In his Master’s project he focused on the novel genome editing technology CRISPR/Cas9 using modal organism Danio rerio and achieved the improvement of knock-in efficiency via modifications in the components of CRISPR/Cas9 system. After his graduation, he continued to work as a scientific assistant in the group of Prof. Englert in the Fritz Lipmann Institute

Rebeca Cordellini Emídio, Ph.D. student